Nice looking results but negative cashflow It's an interesting company, with services for discovering innovation, as well as investments based on IP from universities.Results for the year ended 30 November look good, with an Operating Profit of $4,153,154, which isn't much different from "Gain /(Loss)after tax for the year" (due to only $1,406 income tax expense), and with a higher "Total comprehensive gain for the year" due to a $424,230 currency gain. Those are big numbers compared to the market cap of £7.68m. But, profits were driven by a gain on giving the portfolio a value, of $6,083,225, compared to zero in 2016. You can only give a first-time non-zero valuation once.Cash used in operations was $2,739,179, with $3,051,889 from issuing ordinary shares. There's too much chance of the stock going down as shares are issued to fund the cash burn, for me to invest. Maybe I'm missing out on some great technology, but in my experience, at least for the stock of tiny UK companies, cash burn tends to beat tech quality.The company's site is on [link]
Strategic alliance InventionEvaluator, a division of Tekcapital, provides in-depth analytical reports that assess the commercial potential of new technologies and intellectual property, thereby enabling clients to make more informed decisions regarding investments in new technologies. As part of the Alliance, Health Connexions will make the InventionEvaluator's reports available to its clients and network members worldwide.
Re: Hello? As of today we are nearing break even on issued share capital so should start seeing gradual rise in the SP - though this is a long term hold rather than a trader IMO
Re: Hello? I'm here too. Watching and waiting though. TEK has a good business model, just curious if it will take off.
Hello? Nope - just me then...